Home > Insider Trading > Filing (0001209191-21-064853)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1426332	Ngm Biopharmaceuticals Inc	NGM	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1642996	Jin-Long Chen	333 Oyster Point Boulevard South San Francisco CA 94080	Chief Scientific Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-11-15	15,000	$19.89	884,449	No	4	S	Direct
Common Stock	Disposition	2021-11-15	15,000	$19.56	869,449	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021.
Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $19.66 to $20.24. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $19.29 to $19.90. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.